India, April 8 -- Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with a large footprint in manufacturing and training in India, recently organised a high-level meeting with government stakeholders, and MediTech industry captains in New Delhi. The event was graced by Dr Arunish Chawla, Secretary, Department of Pharmaceuticals (DoP), and MAseem Sahu, Deputy Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).

The event revolved around India's prospects and obstacles within the MediTech domain including tariff and non-tariff barriers, price control, procurement challenges, the need for standard harmonization, and streamlining the regulatory landscape...